These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 16421593)

  • 1. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer.
    Kawakami K; Ruszkiewicz A; Bennett G; Moore J; Grieu F; Watanabe G; Iacopetta B
    Br J Cancer; 2006 Feb; 94(4):593-8. PubMed ID: 16421593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APC gene methylation is inversely correlated with features of the CpG island methylator phenotype in colorectal cancer.
    Iacopetta B; Grieu F; Li W; Ruszkiewicz A; Caruso M; Moore J; Watanabe G; Kawakami K
    Int J Cancer; 2006 Nov; 119(10):2272-8. PubMed ID: 16981189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.
    de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; Weijenberg MP; van Engeland M
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3086-96. PubMed ID: 19843671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation levels of LINE-1 repeats and CpG island loci are inversely related in normal colonic mucosa.
    Iacopetta B; Grieu F; Phillips M; Ruszkiewicz A; Moore J; Minamoto T; Kawakami K
    Cancer Sci; 2007 Sep; 98(9):1454-60. PubMed ID: 17640302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and prognosis value of the CIMP status combined with MLH1 or p16
    Saadallah-Kallel A; Abdelmaksoud-Dammak R; Triki M; Charfi S; Khabir A; Sallemi-Boudawara T; Mokdad-Gargouri R
    Med Oncol; 2017 Aug; 34(8):147. PubMed ID: 28730335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci.
    Kawasaki T; Ohnishi M; Nosho K; Suemoto Y; Kirkner GJ; Meyerhardt JA; Fuchs CS; Ogino S
    Mod Pathol; 2008 Mar; 21(3):245-55. PubMed ID: 18204436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias.
    Konishi K; Shen L; Wang S; Meltzer SJ; Harpaz N; Issa JP
    Gastroenterology; 2007 Apr; 132(4):1254-60. PubMed ID: 17408633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between methylenetetrahydrofolate reductase polymorphism and promoter methylation in proximal colon cancer.
    Oyama K; Kawakami K; Maeda K; Ishiguro K; Watanabe G
    Anticancer Res; 2004; 24(2B):649-54. PubMed ID: 15161007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
    Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
    World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
    Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
    Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower specific micronutrient intake in colorectal cancer patients with tumors presenting promoter hypermethylation in p16(INK4a), p4(ARF) and hMLH1.
    Mas S; Lafuente MJ; Crescenti A; Trias M; Ballesta A; Molina R; Zheng S; Wiencke JK; Lafuente A
    Anticancer Res; 2007; 27(2):1151-6. PubMed ID: 17465256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dynamic DNA methylation landscape of the
    Savio AJ; Mrkonjic M; Lemire M; Gallinger S; Knight JA; Bapat B
    Clin Epigenetics; 2017; 9():26. PubMed ID: 28293327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas.
    Kim JC; Choi JS; Roh SA; Cho DH; Kim TW; Kim YS
    Ann Surg Oncol; 2010 Jul; 17(7):1767-76. PubMed ID: 20077021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype.
    Toyota M; Ahuja N; Suzuki H; Itoh F; Ohe-Toyota M; Imai K; Baylin SB; Issa JP
    Cancer Res; 1999 Nov; 59(21):5438-42. PubMed ID: 10554013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated age-related CpG island methylation in ulcerative colitis.
    Issa JP; Ahuja N; Toyota M; Bronner MP; Brentnall TA
    Cancer Res; 2001 May; 61(9):3573-7. PubMed ID: 11325821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer.
    Wong JJ; Hawkins NJ; Ward RL; Hitchins MP
    Mod Pathol; 2011 Mar; 24(3):396-411. PubMed ID: 21102416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
    An C; Choi IS; Yao JC; Worah S; Xie K; Mansfield PF; Ajani JA; Rashid A; Hamilton SR; Wu TT
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):656-63. PubMed ID: 15701853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter.
    Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H
    Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation in patients with colorectal cancer--correlation with some clinical and morphological features and with local tumour invasion.
    Mirchev MB; Kahl P; Friedrichs N; Kotzev IA; Buettner R
    Folia Med (Plovdiv); 2010; 52(2):22-30. PubMed ID: 20836393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer.
    Nosho K; Shima K; Irahara N; Kure S; Baba Y; Kirkner GJ; Chen L; Gokhale S; Hazra A; Spiegelman D; Giovannucci EL; Jaenisch R; Fuchs CS; Ogino S
    Clin Cancer Res; 2009 Jun; 15(11):3663-71. PubMed ID: 19470733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.